Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AZD 6912

Next Previous
Drug Profile

AZD 6912

Alternative Names: AZD-6912

Latest Information Update: 14 May 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AstraZeneca
  • Class Antirheumatics; Small interfering RNA
  • Mechanism of Action Complement factor B expression inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Rheumatoid arthritis

Most Recent Events

  • 31 Mar 2026 AstraZeneca terminates a phase I trial in Rheumatoid arthritis in the United Kingdom and Canada (PO), due to strategic reasons (NCT06115967) (AstraZeneca pipeline, May 2026)
  • 15 Dec 2025 AstraZeneca completes a phase I trial in Rheumatoid arthritis in the United Kingdom and Canada (PO) (NCT06115967)
  • 12 Jun 2024 Updated pharmacodynamics data from a preclinical trial in Rheumatoid arthritis presented at the 25th Annual Congress of the European League Against Rheumatism (EULAR-2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top